Notable Stock Analysts Ratings: Fluent, Inc.(NASDAQ:FLNT): Amphastar Pharmaceuticals, Inc.(NASDAQ:AMPH)

0
1

Fluent, Inc. (FLNT) will report its next earnings on Mar 10 AMC. The company reported the earnings of $-0.06/Share in the last quarter where the estimated EPS by analysts was $0.02/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -400%.

Many analysts are providing their Estimated Earnings analysis for Fluent, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $0.02/share. These analysts have also projected a Low Estimate of $0.02/share and a High Estimate of $0.03/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Fluent, Inc. as 79.61 Million. According to these analysts, the Low Revenue Estimate for Fluent, Inc. is 79.2 Million and the High Revenue Estimate is 80.03 Million. The company had Year Ago Sales of 70.82 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for FLNT to be -62.5%. They are projecting Next Quarter growth of -120%. For the next 5 years, Fluent, Inc. is expecting Growth of 150% per annum, whereas in the past 5 years the growth was -125% per annum.

Some buy side analysts are also providing their Analysis on Fluent, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.24 and Average Volume (3 months) is 662.35 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -0.4%. The Return on Equity (ROE) value stands at -0.5%. While it’s Return on Investment (ROI) value is 4.3%.

While looking at the Stock’s Performance, Fluent, Inc. currently shows a Weekly Performance of -6.03%, where Monthly Performance is 15.72%, Quarterly performance is 4.33%, 6 Months performance is -16.93% and yearly performance percentage is -40.72%. Year to Date performance value (YTD perf) value is 6%. The Stock currently has a Weekly Volatility of 7.03% and Monthly Volatility of 8.72%.

Amphastar Pharmaceuticals, Inc. (AMPH) will report its next earnings on Mar 10 AMC. The company reported the earnings of $0.1/Share in the last quarter where the estimated EPS by analysts was $0.07/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 42.9%.

Many analysts are providing their Estimated Earnings analysis for Amphastar Pharmaceuticals, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $0.07/share. These analysts have also projected a Low Estimate of $-0.01/share and a High Estimate of $0.13/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Amphastar Pharmaceuticals, Inc. as 81.79 Million. According to these analysts, the Low Revenue Estimate for Amphastar Pharmaceuticals, Inc. is 77.8 Million and the High Revenue Estimate is 87.2 Million. The company had Year Ago Sales of 89.69 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for AMPH to be -61.5%. They are projecting Next Quarter growth of -10%. For the next 5 years, Amphastar Pharmaceuticals, Inc. is expecting Growth of 74.19% per annum, whereas in the past 5 years the growth was 47.62% per annum.

The Relative Volume of the company is 0.78 and Average Volume (3 months) is 223.65 million. The company’s P/E (price to earnings) ratio is 19.18 and Forward P/E ratio of 30.8.

The company shows its Return on Assets (ROA) value of 9.2%. The Return on Equity (ROE) value stands at 14.4%. While it’s Return on Investment (ROI) value is -1.4%.

While looking at the Stock’s Performance, Amphastar Pharmaceuticals, Inc. currently shows a Weekly Performance of 1.99%, where Monthly Performance is 6.39%, Quarterly performance is 15.25%, 6 Months performance is -4.12% and yearly performance percentage is -16.22%. Year to Date performance value (YTD perf) value is 3.63%. The Stock currently has a Weekly Volatility of 1.47% and Monthly Volatility of 2.22%.

SHARE